Kursprognose für MaxCyte Inc (MXCT)MXCTMaxCyte Inc

Alphio's MXCT stock price prediction model matches the current MaxCyte Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $1.33 (+1.62%). The 1-week path is $1.31 (-0.29%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

MaxCyte Inc is currently trading at $1.45, which is 69.4% of its 52-week range, indicating it is closer to its high of $1.80 than its low of $0.64. However, the RSI is at 45.41, suggesting that the stock is neither overbought nor oversold. The company has a forward P/E of 0, reflecting uncertainty in future earnings, and a gross margin of 63.86%, which is relatively strong. The main risk is the negative net income reported, with a loss of $8.87 million in Q2 2026, indicating ongoing financial struggles. Therefore, while there are some positive indicators, the overall financial performance and lack of clear upward momentum suggest holding rather than buying right now.

MaxCyte Inc (MXCT) last closed at $1.3099999, losing -5.76%. These facts feed the 1-day and 1-week MXCT price prediction above.